[Clinical effectiveness of plasmapheresis and lymphocytoplasmapheresis in patients with systemic scleroderma].
Clinical effect of plasma- and lymphoplasmapheresis in patients with various patterns of sclerodermia systematica was studied in 12 females with subacute and chronic course of the disease. The failure of the drug therapy preceded, the complications associated with corticosteroid treatment performed were the indications to the aforementioned procedures. The treatment course comprised 3-5 procedures with an interval of 2-3 days. During 1 plasmapheresis session 1000-1200 ml of the plasma were removed and 1100-1250 ml of the plasma and 4.5.10(9)-7.0.10(9) lymphocytes were removed by a session of lymphoplasmapheresis. The results obtained evidenced a positive influence of plasma- and lymphoplasmapheresis on the course of sclerodermia systematica, contributed to a decrease in the clinical manifestation of the disease and laboratory data indicating the activity of inflammation, led to a more rapid regression of the main symptoms of the disease than it was recorded during the routine treatment, promoted a longer remission and a significant reduction of the hormone dosage.
Vlasenko
A N
AN
Vorob'ev
A A
AA
Matveev
S Iu
SIu
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D005260:Female; D006801:Humans; D007962:Leukocytes; D008875:Middle Aged; D010956:Plasmapheresis; D012595:Scleroderma, Systemic / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D013997:Time Factors
D000305:Adrenal Cortex Hormones
Klinicheskaia éffektivnost' plazmafereza i limfotsitoplazmafereza u bol'nykh sistemnoĭ sklerodermieĭ.